Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Fenretinide
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
SciTech Readies for First-in-Human Trial with Clinical Supply of ST-001 nanoFenretinide
Details : ST-001 (nanoFenretinide) is the patented formulation that enables the safe and rapid infusion of high-dose fenretinide, which is investigated for the treatment of cancer.
Brand Name : ST-001
Molecule Type : Small molecule
Upfront Cash : Not Applicable
October 03, 2023
Lead Product(s) : Fenretinide
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?